Listen up, folks, we’ve got something incredible here with cangrelor!

So, we’ve been looking into this amazing drug, cangrelor, right? It’s like a bridge, a fantastic bridge when you need to stop the usual heart meds for a bit. But here’s the thing – we’re not totally sure about the best dose or how to check it’s working, especially when you’ve got these big, beautiful machines helping the heart (that’s mechanical circulatory support, MCS).

We did this huge, tremendous study, very observational and retrospective, at a single center. We’re talking about patients who had a PCI – that’s a procedure to open up heart arteries – within the last 3 months and then got cangrelor in the ICU. We were looking for major heart problems, which we call MACE, and also checking how well the drug was working with this VerifyNow® thing, and any bleeding.

Out of 92 patients, only one had a major heart problem – that’s 1.1%, incredibly low. And guess what? Most of these patients, a whopping 89%, hit the target for how well the drug was working. The median value was 115 PRU – that’s a number from the VerifyNow® test. But, we did see some bleeding in about 23% of patients.

What we found is that our protocol for giving cangrelor to these very sick patients, it’s working, it’s successful. We’re hitting our goals. But we’re still figuring out the best test results to aim for, to keep the balance between preventing clots and bleeding. We need more studies, big, beautiful randomized trials to figure out the perfect numbers.

So, to all the heart doctors out there, keep an eye on those PRU levels when you’re using cangrelor. It’s going to help you make the best decisions for your patients. And believe me, we’re going to make heart care great with this!